title: Topical Ruxolitinib for the Treatment of Alopecia Universalis.
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Brittany G
authors.initials: BG
authors.lastname: Craiglow
authors.affiliation: Quality Care Drug, Centerbrook, Connecticut.
authors.forename: Daniel
authors.initials: D
authors.lastname: Tavares
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Brett A
authors.initials: BA
authors.lastname: King
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000505:Alopecia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D009570:Nitriles; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D011720:Pyrazoles / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines; D016896:Treatment Outcome
chemical_list: D009570:Nitriles; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases